$DOMH
Dominari Holdings Inc. Stock $domh

$domh Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000121390023025306 Filed on March 31, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$3.833M	$3.120M	$11.68M
YoY Change	114.49%	24.65%	51.06%
% of Gross Profit
Research & Development	$0.00	$30.00K	$830.0K
YoY Change	-100.0%	-63.41%	-51.38%
% of Gross Profit
Depreciation & Amortization	$7.000K		$0.00
YoY Change
% of Gross Profit
Operating Expenses	$3.834M	$3.140M	$14.35M
YoY Change	0.82%	21.47%	51.95%
Operating Profit	-$3.834M		-$14.35M
YoY Change	0.82%		51.95%
Interest Expense	$70.00K	-$4.110M	-$7.830M
YoY Change	-65.69%	-630.32%	-466.74%
% of Operating Profit
Other Income/Expense, Net	$72.00K	$0.00	-$7.761M
YoY Change	12.5%		-5848.89%
Pretax Income	-$3.760M	-$7.260M	-$22.11M
YoY Change	6.36%	301.1%	208.33%
Income Tax
% Of Pretax Income
Net Earnings	-$3.762M	-$7.260M	-$22.11M
YoY Change	6.42%	301.1%	208.28%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.71		-$4.91
Diluted Earnings Per Share	-$0.71	-$1.32	-$4.91
COMMON SHARES
Basic Shares Outstanding	4.841M shares	5.485M shares	5.334M shares
Diluted Shares Outstanding	5.306M shares		5.334M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$33.93M	$40.30M	$42.30M
YoY Change	-50.52%	-51.71%	-49.32%
Cash & Equivalents	$9.533M	$33.17M
Short-Term Investments	$24.39M	$7.130M	$9.100M
Other Short-Term Assets	$4.300M	$900.0K	$900.0K
YoY Change	-79.81%	103.62%	103.62%
Inventory
Prepaid Expenses		$301.0K
Receivables	$6.500M	$7.500M	$7.500M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$44.77M	$50.66M	$50.70M
YoY Change	-54.86%	-44.27%	-44.22%
LONG-TERM ASSETS
Property, Plant & Equipment	$353.0K		$900.0K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$23.10M	$23.10M	$23.10M
YoY Change	24.13%	144.06%	144.06%
Other Assets	$500.0K	$500.0K	$500.0K
YoY Change	222.58%	222.58%	222.58%
Total Long-Term Assets	$29.38M	$25.58M	$25.50M
YoY Change	56.58%	117.39%	116.71%
TOTAL ASSETS
Total Short-Term Assets	$44.77M	$50.66M	$50.70M
Total Long-Term Assets	$29.38M	$25.58M	$25.50M
Total Assets	$74.15M	$76.24M	$76.20M
YoY Change	-37.13%	-25.74%	-25.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$600.0K	$400.0K	$400.0K
YoY Change	187.08%	4.99%	4.99%
Accrued Expenses	$1.000M	$1.300M	$1.300M
YoY Change	45.77%	91.18%	91.18%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.720M	$1.789M	$1.800M
YoY Change	92.18%	68.61%	69.65%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.400M	$700.0K	$700.0K
YoY Change
Total Long-Term Liabilities	$3.400M	$700.0K	$700.0K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.720M	$1.789M	$1.800M
Total Long-Term Liabilities	$3.400M	$700.0K	$700.0K
Total Liabilities	$5.083M	$2.469M	$2.500M
YoY Change	467.93%	132.7%	135.63%
SHAREHOLDERS EQUITY
Retained Earnings	-$189.6M	-$185.9M
YoY Change		13.5%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$501.0K	$3.322M
YoY Change		1158.33%
Treasury Stock Shares
Shareholders Equity	$69.07M	$73.77M	$73.80M
YoY Change
Total Liabilities & Shareholders Equity	$74.15M	$76.24M	$76.20M
YoY Change	-37.13%	-25.74%	-25.77%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$3.762M	-$7.260M	-$22.11M
YoY Change	6.42%	301.1%	208.28%
Depreciation, Depletion And Amortization	$7.000K		$0.00
YoY Change
Cash From Operating Activities	-$3.991M	-$1.860M	-$10.60M
YoY Change	4.04%	-9.18%	60.49%
INVESTING ACTIVITIES
Capital Expenditures	$360.0K	$1.300M	$1.830M
YoY Change		-6600.0%	-396.6%
Acquisitions
YoY Change
Other Investing Activities	-$18.35M	$2.660M	-$12.77M
YoY Change	82.08%	-95.67%	55.05%
Cash From Investing Activities	-$18.71M	$1.360M	-$14.60M
YoY Change	85.66%	-97.79%	64.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$3.058M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$939.0K	-820.0K	-$7.193M
YoY Change	-104.94%	-456.52%	-109.19%
NET CHANGE
Cash From Operating Activities	-$3.991M	-1.860M	-$10.60M
Cash From Investing Activities	-$18.71M	1.360M	-$14.60M
Cash From Financing Activities	-$939.0K	-820.0K	-$7.193M
Net Change In Cash	-$23.64M	-1.320M	-$32.39M
YoY Change	-565.65%	-102.21%	-151.53%
FREE CASH FLOW
Cash From Operating Activities	-$3.991M	-$1.860M	-$10.60M
Capital Expenditures	$360.0K	$1.300M	$1.830M
Free Cash Flow	-$4.351M	-$3.160M	-$12.43M
YoY Change	13.43%	55.82%	107.6%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-05576
CY2022	dei	Entity Registrant Name EntityRegistrantName	DOMINARI HOLDINGS INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	52-0849320
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	One Rockefeller Plaza
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	11th Floor
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10020
CY2022	dei	City Area Code CityAreaCode	703
CY2022	dei	Local Phone Number LocalPhoneNumber	992-9325
CY2022	dei	Security12b Title Security12bTitle	Common Stock ($0.0001 par value per share)
CY2022	dei	Trading Symbol TradingSymbol	DOMH
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	30913061	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4840597	shares
CY2022	dei	Auditor Firm AuditorFirmId	688
CY2022	dei	Auditor Name AuditorName	Marcum llp
CY2022	dei	Auditor Location AuditorLocation	New York NY
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33174000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65562000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	7130000	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	11427000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	564000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	442000	usd
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	301000	usd
CY2022Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments	13000	usd
CY2021Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments	2273000	usd
CY2022Q4	us-gaap	Notes Receivable Related Parties Current NotesReceivableRelatedPartiesCurrent	7474000	usd
CY2021Q4	us-gaap	Notes Receivable Related Parties Current NotesReceivableRelatedPartiesCurrent	6984000	usd
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	4201000	usd
CY2022Q4	domh	Investment In Field Point Securitie InvestmentInFieldPointSecuritie	2000000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	50656000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	90889000	usd
CY2021Q4	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties	2147000	usd
CY2022Q4	us-gaap	Notes Receivable Related Parties Noncurrent NotesReceivableRelatedPartiesNoncurrent	1100000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	23103000	usd
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	9465000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	919000	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	458000	usd
CY2021Q4	us-gaap	Security Deposit SecurityDeposit	155000	usd
CY2022Q4	us-gaap	Assets Assets	76236000	usd
CY2021Q4	us-gaap	Assets Assets	102656000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	447000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	381000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1260000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	680000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	82000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1789000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1061000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	680000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2469000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	1061000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5485096	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5275329	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5017079	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5275329	shares
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	262970000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	265633000	usd
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	468017	shares
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	0	shares
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3322000	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	264000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-185881000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-163774000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	73767000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	101595000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	76236000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	102656000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11683000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7734000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	830000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	559000	usd
CY2022	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	1833000	usd
CY2021	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	1148000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	14346000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	9441000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-14346000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-9441000	usd
CY2022	us-gaap	Other Income OtherIncome	64000	usd
CY2021	us-gaap	Other Income OtherIncome	135000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	687000	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	252000	usd
CY2022	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-5952000	usd
CY2021	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-1743000	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	-2560000	usd
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	3626000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7761000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2270000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-22107000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-7171000	usd
CY2022	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	4109000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-26216000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-7171000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.91
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.48
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5334075	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4846925	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	29618000	usd
CY2021	domh	Warrant Net Offering Costs WarrantNetOfferingCosts	8031000	usd
CY2021	domh	Stock Issued During Period Value Of Common Stock And Warrants StockIssuedDuringPeriodValueOfCommonStockAndWarrants	78219000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	84000	usd
CY2021	domh	Stock Issued During Period Value Issued For Research And Development License Acquired StockIssuedDuringPeriodValueIssuedForResearchAndDevelopmentLicenseAcquired	531000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	314000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-7171000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	101595000	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	-4109000	usd
CY2022	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	3058000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	1472000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Stock Split AdjustmentsToAdditionalPaidInCapitalStockSplit	-26000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-22107000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	73767000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-22107000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-7171000	usd
CY2022	domh	Amortization Of Rightofuse Assets AmortizationOfRightofuseAssets	188000	usd
CY2022	domh	Change In Fair Value Of Shortterm Investment ChangeInFairValueOfShorttermInvestment	2621000	usd
CY2021	domh	Change In Fair Value Of Shortterm Investment ChangeInFairValueOfShorttermInvestment	-3626000	usd
CY2022	domh	Change In Fair Value Of Longterm Investment ChangeInFairValueOfLongtermInvestment	-61000	usd
CY2022	domh	Research And Developmentacquired License Expensed ResearchAndDevelopmentacquiredLicenseExpensed	1833000	usd
CY2021	domh	Research And Developmentacquired License Expensed ResearchAndDevelopmentacquiredLicenseExpensed	1148000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1472000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	314000	usd
CY2022	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-1405000	usd
CY2021	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-67000	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-4867000	usd
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-3115000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	215000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	227000	usd
CY2022	domh	Increase Decrease In Prepaid Acquisition Cost IncreaseDecreaseInPrepaidAcquisitionCost	301000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	66000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-186000	usd
CY2022	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	580000	usd
CY2021	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	370000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	31000	usd
CY2022	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	600000	usd
CY2021	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	252000	usd
CY2021	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	155000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10597000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6603000	usd
CY2022	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	2000000	usd
CY2022	domh	Purchase Of Marketable Securities PurchaseOfMarketableSecurities	26798000	usd
CY2021	domh	Purchase Of Marketable Securities PurchaseOfMarketableSecurities	93432000	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	28658000	usd
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	103043000	usd
CY2022	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	93000	usd
CY2021	domh	Proceeds From Sale Of Dat Chat Common Shares ProceedsFromSaleOfDatChatCommonShares	900000	usd
CY2022	domh	Return Of Depositfunding Of Deposit Into A Managed Account Net ReturnOfDepositfundingOfDepositIntoAManagedAccountNet	-3898000	usd
CY2021	domh	Return Of Depositfunding Of Deposit Into A Managed Account Net ReturnOfDepositfundingOfDepositIntoAManagedAccountNet	4201000	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	15016000	usd
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	5666000	usd
CY2022	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	1833000	usd
CY2021	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	617000	usd
CY2022	domh	Purchase Of Shortterm And Longterm Promissory Notes PurchaseOfShorttermAndLongtermPromissoryNotes	1600000	usd
CY2021	domh	Purchase Of Shortterm And Longterm Promissory Notes PurchaseOfShorttermAndLongtermPromissoryNotes	6880000	usd
CY2021	domh	Purchase Of Convertible Note PurchaseOfConvertibleNote	2000000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14598000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8853000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	78219000	usd
CY2022	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	17891000	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	84000	usd
CY2022	domh	Payment For Fractional Shares PaymentForFractionalShares	26000	usd
CY2022	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	-22000000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3058000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-7193000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	78303000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-32388000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	62847000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	65562000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2715000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33174000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	65562000	usd
CY2022	domh	Transfer From Shortterm Investment To Marketable Securites TransferFromShorttermInvestmentToMarketableSecurites	1497000	usd
CY2022	domh	Transfer From Longterm Investment To Marketable Securites TransferFromLongtermInvestmentToMarketableSecurites	1439000	usd
CY2022	domh	Reclassify From Convertible Note Receivable To Notes Receivable At Fair Value ReclassifyFromConvertibleNoteReceivableToNotesReceivableAtFairValue	2147000	usd
CY2022	domh	Promissory Convertible Note Receivable Conversion Into Common Shares PromissoryConvertibleNoteReceivableConversionIntoCommonShares	899000	usd
CY2022Q3	domh	Membership Interests MembershipInterests	1	pure
CY2022Q4	domh	Investments Company Fee Paid Indirectly InvestmentsCompanyFeePaidIndirectly	2000000	usd
CY2022Q4	domh	Membership Interests MembershipInterests	0.20	pure
CY2022	us-gaap	Investment Company Fee Paid Indirectly InvestmentCompanyFeePaidIndirectly	1	usd
CY2022	domh	Membership Interests MembershipInterests	0.80	pure
CY2022	domh	Reverse Stock Split ReverseStockSplit	26000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Use of Estimates</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying consolidated financial statements have been prepared in conformity with US GAAP. This requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the period. The Company’s significant estimates and assumptions include stock-based compensation, the valuation of investments, the valuation of notes receivable and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates and assumptions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Concentration of Cash</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company maintains cash balances at two financial institutions in checking accounts. From time to time, the Company’s cash account balances exceed the balances as covered by the Federal Deposit Insurance System. The Company has never suffered a loss due to such excess balances. As of December 31, 2022 and 2021, the Company had no cash equivalents.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2021Q2	us-gaap	Deposits Deposits	5000000	usd
CY2022Q4	us-gaap	Custody Fees CustodyFees	8000	usd
CY2021	us-gaap	Custody Fees CustodyFees	800000	usd
CY2022Q4	us-gaap	Deposit Assets DepositAssets	0	usd
CY2021Q4	us-gaap	Deposit Assets DepositAssets	4200000	usd
CY2022Q4	domh	Investments Company Fee Paid Indirectly InvestmentsCompanyFeePaidIndirectly	2000000	usd
CY2022Q4	domh	Membership Interests MembershipInterests	0.20	pure
CY2022Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	2000000	usd
CY2022	domh	Released Amount ReleasedAmount	2000000	usd
CY2022Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	2000000	usd
CY2022	domh	Excise Tax ExciseTax	0.01	pure
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-4867000	usd
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-3115000	usd
CY2022	us-gaap	Dividend Income Operating DividendIncomeOperating	320000	usd
CY2021	us-gaap	Dividend Income Operating DividendIncomeOperating	1439000	usd
CY2022	domh	Marketable Securities Gain Losses MarketableSecuritiesGainLosses	-5952000	usd
CY2021Q1	domh	Exchange Shares ExchangeShares	500	shares
CY2022	domh	Nonrefundable Cash Payment NonrefundableCashPayment	500000	usd
CY2022	domh	Net Sales Percentage NetSalesPercentage	0.02	pure
CY2022	us-gaap	Proceeds From License Fees Received ProceedsFromLicenseFeesReceived	1800000	usd
CY2022	domh	Realizedloss Gain RealizedlossGain	1405000	usd
CY2021	domh	Realizedloss Gain RealizedlossGain	67000	usd
CY2021	domh	Marketable Securities Gain Losses MarketableSecuritiesGainLosses	-1743000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	13000	usd
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	2273000	usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2273000	usd
CY2022	domh	Transfer To Marketable Securitie TransferToMarketableSecuritie	-1497000	usd
CY2022	domh	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Losses FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLosses	-763000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	13000	usd
CY2022Q3	us-gaap	Shares Issued SharesIssued	35714	shares
CY2022Q4	us-gaap	Other Investments OtherInvestments	0	usd
CY2022Q4	us-gaap	Alternative Investment AlternativeInvestment	23103000	usd
CY2021Q4	us-gaap	Alternative Investment AlternativeInvestment	9465000	usd
CY2021Q4	us-gaap	Investments And Cash InvestmentsAndCash	9465000	usd
CY2022	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	15016000	usd
CY2022	domh	Change In Fair Value Of Longterm Investments ChangeInFairValueOfLongtermInvestments	61000	usd
CY2022	domh	Transfer To Marketable Securities TransferToMarketableSecurities	-1439000	usd
CY2022Q4	us-gaap	Investments And Cash InvestmentsAndCash	23103000	usd
CY2021Q3	domh	Interest Interest	1000000	usd
	domh	Lower Valuation LowerValuation	48.16
CY2022Q4	us-gaap	Stock Dividends Shares StockDividendsShares	600000	shares
CY2022Q4	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1400000	usd
CY2022Q4	us-gaap	Unrealized Gain On Securities UnrealizedGainOnSecurities	100000	usd
CY2021Q4	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	250000	shares
CY2021Q4	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1000000	usd
CY2021	us-gaap	Investment Income Net InvestmentIncomeNet	1000000	usd
CY2022Q2	us-gaap	Purchase Obligation PurchaseObligation	2000000	usd
CY2022Q4	domh	Per Share PerShare	0.5
CY2022Q1	us-gaap-sup	Payable Investment Purchase PayableInvestmentPurchase	1500000	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	7474000	usd
CY2021Q1	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	2000000	usd
CY2022Q1	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	4800000	usd
CY2022Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.08	pure
CY2022Q4	us-gaap	Interest Receivable Noncurrent InterestReceivableNoncurrent	26000	usd
CY2021Q3	domh	Convertible Promissory Note ConvertiblePromissoryNote	0.08	pure
CY2021Q3	domh	Stock Issued During Period Shares Of Common Stock And Warrants StockIssuedDuringPeriodSharesOfCommonStockAndWarrants	933333	shares
CY2021Q3	us-gaap	Financing Receivable Purchased With Credit Deterioration Amount At Purchase Price FinancingReceivablePurchasedWithCreditDeteriorationAmountAtPurchasePrice	1400000	usd
CY2021Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.08	pure
CY2021Q4	us-gaap	Interest Receivable Noncurrent InterestReceivableNoncurrent	45000	usd
CY2022Q2	us-gaap	Interest Receivable Noncurrent InterestReceivableNoncurrent	63000	usd
CY2022Q2	domh	Stock Issued During Period Shares Of Common Stock And Warrants StockIssuedDuringPeriodSharesOfCommonStockAndWarrants	558659	shares
CY2022	domh	Stock Issued During Period Shares Of Common Stock And Warrants StockIssuedDuringPeriodSharesOfCommonStockAndWarrants	558659	shares
CY2021Q4	domh	Convertible Promissory Note ConvertiblePromissoryNote	0.10	pure
CY2021Q4	domh	Number Of Common Shares Issuable NumberOfCommonSharesIssuable	0.50	pure
CY2021Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.10	pure
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	750000	usd
CY2022Q4	us-gaap	Investments Investments	0	usd
CY2022	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	7130000	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	7130000	usd
CY2022Q4	domh	Shortterm Investments ShorttermInvestments	13000	usd
CY2022Q4	us-gaap	Shortterm Debt Fair Value ShorttermDebtFairValue	7474000	usd
CY2022Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	1100000	usd
CY2021Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	11427000	usd
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities	11427000	usd
CY2021Q4	domh	Shortterm Investments ShorttermInvestments	2273000	usd
CY2021Q4	domh	Notes Receivable At Fair Value NotesReceivableAtFairValue	6984000	usd
CY2021Q4	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	2147000	usd
CY2022	domh	Common Stock Shares CommonStockShares	558659	shares
CY2022Q4	us-gaap	Investment Interest Rate InvestmentInterestRate	0.08	pure
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	500000	usd
CY2021Q4	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	13502	usd
CY2022Q3	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	49368	usd
CY2022Q3	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	51868	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	919000	usd
CY2022Q4	domh	Operating Lease Current OperatingLeaseCurrent	82000	usd
CY2022Q4	domh	Operating Lease Long Term1 OperatingLeaseLongTerm1	680000	usd
CY2022Q4	domh	Operating Leases Liability OperatingLeasesLiability	762000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y1M6D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2022	us-gaap	Lease Cost LeaseCost	100000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	73	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	73	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	67	usd
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	140	usd
CY2022	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	231000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	960000	usd
CY2022	domh	Term Of Future Minimum Payments TermOfFutureMinimumPayments	P5Y
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths	154000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	154000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	142000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	142000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	142000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	337000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1071000	usd
CY2022Q4	domh	Less Present Value Discount LessPresentValueDiscount	-309000	usd
CY2022Q4	domh	Operating Lease Liabilities OperatingLeaseLiabilities	762000	usd
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	499552	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	369505	shares
CY2022Q1	us-gaap	Restricted Cash And Investments RestrictedCashAndInvestments	21000000	usd
CY2022	domh	Aggregate Cash Fee Percentage AggregateCashFeePercentage	0.08	pure
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	103528	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	21.25
CY2022	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	1.05	pure
	us-gaap	Debt Instrument Description DebtInstrumentDescription	the Company redeemed for cash at a price equal to 105% of the $1,000 stated value per share all of its 11,000 outstanding shares of Series O Preferred Stock and its 11,000 Series P Preferred Stock.
CY2022Q2	us-gaap	Debt Default Longterm Debt Amount DebtDefaultLongtermDebtAmount	23100000	usd
CY2022	us-gaap	Dividends Dividends	4100000	usd
CY2021Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	2757352	shares
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	75000000	usd
CY2021Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	78200000	usd
CY2022	domh	Percentage Of Stock Sold PercentageOfStockSold	0.08	pure
CY2022	domh	Warrants Exercisable Term WarrantsExercisableTerm	P5Y
CY2022Q1	domh	Share Buyback Program Amount ShareBuybackProgramAmount	3000000	usd
CY2022	domh	Share Repurchased ShareRepurchased	468017	shares
CY2022	domh	Amount Of Cost AmountOfCost	3100000	usd
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	6.53
CY2022Q4	domh	Treasury Stock Common Share TreasuryStockCommonShare	1373	shares
CY2022	domh	Voting Power Percentage VotingPowerPercentage	0.50	pure
CY2021Q3	us-gaap	Stockholders Equity Note Changes In Capital Structure Subsequent Changes To Number Of Common Shares StockholdersEquityNoteChangesInCapitalStructureSubsequentChangesToNumberOfCommonShares	1470	shares
CY2021Q3	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	100000	usd
CY2022	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	238244	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P0Y3D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	238244	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.13
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	230176	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	6.15
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	8068	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	5.64
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense	300	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	22591	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	680.79
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	68996000	usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y10M24D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	5882	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	21.08
CY2021	domh	Employee Options Granted Weighted Average Remaining Contractual Lifein Years EmployeeOptionsGrantedWeightedAverageRemainingContractualLifeinYears	P9Y1M6D
CY2021	domh	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expiration ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiration	270	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	28203	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	548.35
CY2021	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P8Y2M12D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	170587	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.95
CY2022	domh	Employee Options Granted Weighted Average Remaining Contractual Lifein Years EmployeeOptionsGrantedWeightedAverageRemainingContractualLifeinYears	P0Y3M18D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	167381	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	41.9
CY2022	domh	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expiration ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiration	216	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	73.7
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	31193	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	302.97
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P7Y10M24D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	25311	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	372
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y7M6D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	5.95
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	21.08
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.17	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.241	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0292	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0045	pure
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	13000	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	200000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	76000	usd
CY2022Q4	domh	Share Grant ShareGrant	25537	shares
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-3618000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1581000	usd
CY2022	domh	Increase Decrease In Valuation Allowance Federal IncreaseDecreaseInValuationAllowanceFederal	3618000	usd
CY2021	domh	Increase Decrease In Valuation Allowance Federal IncreaseDecreaseInValuationAllowanceFederal	1581000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-4825000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	2492000	usd
CY2022	domh	Increase In Valuation Allowance State And Local IncreaseInValuationAllowanceStateAndLocal	4825000	usd
CY2021	domh	Increase In Valuation Allowance State And Local IncreaseInValuationAllowanceStateAndLocal	-2492000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.1358	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.0011	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.0087	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	0.0295	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	-0.0565	pure
CY2022	domh	Decrease Due To True Up Of State Nol DecreaseDueToTrueUpOfStateNOL	0.0069	pure
CY2021	domh	Decrease Due To True Up Of State Nol DecreaseDueToTrueUpOfStateNOL	-0.4495	pure
CY2022	domh	Decrease Due To Change In Federal Nol And Other True Ups Percent DecreaseDueToChangeInFederalNOLAndOtherTrueUpsPercent	0.0004	pure
CY2021	domh	Decrease Due To Change In Federal Nol And Other True Ups Percent DecreaseDueToChangeInFederalNOLAndOtherTrueUpsPercent	0.1296	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.3815	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.1751	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	26241000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	20161000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	8358000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	8196000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	15299000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	13917000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	49898000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	42274000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	49115000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	39759000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	783000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2516000	usd
CY2022Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	726000	usd
CY2021Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	2516000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	56000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	9400000	usd
CY2022	domh	Description Of Operating Loss Carryforwards Expiration DescriptionOfOperatingLossCarryforwardsExpiration	the Company has approximately $41 million federal net operating loss carryovers (“NOLs”), which expire from 2033 through 2037
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	41000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	49000000	usd
CY2022	domh	State And City Nol Expiration Description StateAndCityNOLExpirationDescription	The Company has approximately $113 million of state and city NOLs, which expire from 2024 through 2041
CY2022	domh	Percentage Of Ownership PercentageOfOwnership	0.50	pure
CY2022	domh	Ultimate Settlement UltimateSettlement	0.50	pure
CY2022	us-gaap	Interest Costs Incurred InterestCostsIncurred	1000000	usd
CY2021	us-gaap	Interest Costs Incurred InterestCostsIncurred	1200000	usd
CY2022	us-gaap	Restricted Stock Expense RestrictedStockExpense	1000000	usd
CY2022	domh	Bonus Bonus	50000	usd
CY2021Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts		usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent		usd
CY2022Q4	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties		usd
CY2021Q4	us-gaap	Notes Receivable Related Parties Noncurrent NotesReceivableRelatedPartiesNoncurrent		usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4846925	shares
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Split AdjustmentsToAdditionalPaidInCapitalStockSplit		usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued		usd
CY2022	domh	Redemption Of Series O Redeemable Convertible Preferred Stock RedemptionOfSeriesORedeemableConvertiblePreferredStock		usd
CY2022	domh	Redemption Of Series P Redeemable Convertible Preferred Stock RedemptionOfSeriesPRedeemableConvertiblePreferredStock		usd
CY2022	domh	Distribution Of Hoth Common Stock DistributionOfHothCommonStock		usd
CY2021	domh	Amortization Of Rightofuse Assets AmortizationOfRightofuseAssets		usd
CY2021	domh	Change In Fair Value Of Longterm Investment ChangeInFairValueOfLongtermInvestment		usd
CY2021	domh	Increase Decrease In Prepaid Acquisition Cost IncreaseDecreaseInPrepaidAcquisitionCost		usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2022	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets		usd
CY2021	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments		usd
CY2021	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets		usd
CY2022	domh	Proceeds From Sale Of Dat Chat Common Shares ProceedsFromSaleOfDatChatCommonShares		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2021	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2021	domh	Payment For Fractional Shares PaymentForFractionalShares		usd
CY2021	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock		usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2021	domh	Transfer From Shortterm Investment To Marketable Securites TransferFromShorttermInvestmentToMarketableSecurites		usd
CY2021	domh	Transfer From Longterm Investment To Marketable Securites TransferFromLongtermInvestmentToMarketableSecurites		usd
CY2021	domh	Reclassify From Convertible Note Receivable To Notes Receivable At Fair Value ReclassifyFromConvertibleNoteReceivableToNotesReceivableAtFairValue		usd
CY2021	domh	Promissory Convertible Note Receivable Conversion Into Common Shares PromissoryConvertibleNoteReceivableConversionIntoCommonShares		usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber		shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2021	domh	Employee Optionsexpired Weighted Average Remaining Contractual Lifein Years EmployeeOptionsexpiredWeightedAverageRemainingContractualLifeinYears
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022	domh	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue		usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited		usd
CY2022	domh	Weighted Average Remaining Contractual Lifein Years Employee Options Forfeited WeightedAverageRemainingContractualLifeinYearsEmployeeOptionsForfeited
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2022	domh	Employee Optionsexpired Weighted Average Remaining Contractual Lifein Years EmployeeOptionsexpiredWeightedAverageRemainingContractualLifeinYears
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit		usd
CY2021	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations		usd
CY2021	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations		usd
CY2022	domh	Amt Credit Benefit AMTCreditBenefit		pure
CY2021	domh	Amt Credit Benefit AMTCreditBenefit		pure
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0000012239

Files In Submission

Name	View Source	Status
domh-20221231_cal.xml	Edgar Link	unprocessable
domh-20221231_lab.xml	Edgar Link	unprocessable
domh-20221231_pre.xml	Edgar Link	unprocessable
0001213900-23-025306-index-headers.html	Edgar Link	pending
0001213900-23-025306-index.html	Edgar Link	pending
0001213900-23-025306.txt	Edgar Link	pending
0001213900-23-025306-xbrl.zip	Edgar Link	pending
domh-20221231.xsd	Edgar Link	pending
f10k2022ex10-29_dominari.htm	Edgar Link	pending
f10k2022ex21-1_dominari.htm	Edgar Link	pending
f10k2022ex23-1_dominari.htm	Edgar Link	pending
f10k2022ex23-2_dominari.htm	Edgar Link	pending
f10k2022ex31-1_dominari.htm	Edgar Link	pending
f10k2022ex32-1_dominari.htm	Edgar Link	pending
f10k2022ex4-6_dominari.htm	Edgar Link	pending
f10k2022_dominari.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
domh-20221231_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10k2022_dominari_htm.xml	Edgar Link	completed
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DOMH
Dominari Holdings Inc. Stock $domh

2023 Q1 Form 10-K Financial Statement

#000121390023025306 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DOMH Dominari Holdings Inc. Stock $domh

2023 Q1 Form 10-K Financial Statement

#000121390023025306 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DOMH
Dominari Holdings Inc. Stock $domh